SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 128 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2015. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $143,000 | -35.0% | 49,421 | 0.0% | 0.12% | -7.8% |
| Q2 2017 | $220,000 | -4.3% | 49,421 | 0.0% | 0.13% | +8.5% |
| Q1 2017 | $230,000 | -46.5% | 49,421 | -29.9% | 0.12% | -3.3% |
| Q4 2016 | $430,000 | -42.2% | 70,530 | -47.8% | 0.12% | -21.3% |
| Q3 2016 | $744,000 | +45.0% | 135,065 | 0.0% | 0.16% | +21.1% |
| Q2 2016 | $513,000 | +60.8% | 135,065 | +16.8% | 0.13% | +29.3% |
| Q1 2016 | $319,000 | -46.8% | 115,670 | +2.1% | 0.10% | -38.1% |
| Q3 2015 | $600,000 | -36.2% | 113,276 | 0.0% | 0.16% | -9.6% |
| Q2 2015 | $940,000 | +79.7% | 113,276 | 0.0% | 0.18% | +90.3% |
| Q1 2015 | $523,000 | +147.9% | 113,276 | +63.9% | 0.09% | +173.5% |
| Q4 2014 | $211,000 | – | 69,110 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,009,984 | $16,683,000 | 6.50% |
| DAFNA Capital Management LLC | 317,563 | $2,636,000 | 2.23% |
| Trellus Management Company, LLC | 162,900 | $1,352,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 246,250 | $2,246,000 | 1.15% |
| WALL STREET ASSOCIATES | 861,200 | $7,148,000 | 0.67% |
| EAM Investors, LLC | 670,346 | $5,564,000 | 0.65% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 200,000 | $1,660,000 | 0.58% |
| CARL DOMINO INC | 66,900 | $555,000 | 0.38% |
| Belmont Global Advisors, Inc. | 36,200 | $300,000 | 0.33% |
| Lombard Odier Asset Management (USA) Corp | 507,223 | $4,210,000 | 0.30% |